In a report released on October 22, David Evans from Kepler Capital maintained a Buy rating on Novartis AG (NOVN – Research Report), ...
Infertility Drugs MarketThe global infertility drugs market is set for significant growth over the next decade, with the ...
US private equity firm Clayton Dubilier & Rice thought it had a deal to buy Sanofi’s consumer business. Losing bidder PAI ...
Personalized Medicine Market. Global Personalized Medicine Market, revealing promising growth trends. The report highlights ...
The global APOL1-mediated kidney disease market is poised for substantial expansion, with projections indicating a remarkable ...
This month, the NCCN Clinical Practice Guidelines in Oncology, NCCN Guidelines, for breast cancer were updated to recommend ribociclib as a ...
Zacks.com on MSN2h
Stay Ahead of the Game With Novartis (NVS) Q3 Earnings: Wall Street's Insights on Key MetricsGet a deeper insight into the potential performance of Novartis (NVS) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for ...
Three absurdly cheap dividend stocks that are trading at modest multiples of their expected earnings today are Merck ( MRK -0 ...
The global ulcerated necrobiosis lipoidica management market is poised for significant growth, with an anticipated valuation ...
The NCCN has updated its breast cancer guidelines, designating Novartis' Kisqali as a Category 1 preferred CDK4/6 inhibitor ...
In addition to the recent FDA approval of Kisqali for EBC patients in the US and CHMP positive opinion in Europe, regulatory ...
Roche will use Dyno’s technology, through which Dyno applies AI and high-throughput in vivo data collection to engineering AAV capsids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback